HKSE:03933 (Hong Kong)
Â
Ordinary Shares
HK$
8.67
(+0.12%)
Aug 27
Business Description
United Laboratories International Holdings Ltd
ISIN : KYG8813K1085
Share Class Description:
HKSE:03933: Ordinary SharesCompare
Compare
Traded in other countries / regions
03933.Hong KongUNJ.GermanyULIHF.USA IPO Date
2007-06-15Description
United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.83 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.38 | |||||
Interest Coverage | 49.17 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.1 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | 28.6 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year FCF Growth Rate | -5.3 | |||||
3-Year Book Growth Rate | 11.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 2.68 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.08 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.36 | |||||
9-Day RSI | 47.97 | |||||
14-Day RSI | 49.23 | |||||
6-1 Month Momentum % | 8.2 | |||||
12-1 Month Momentum % | 26.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.08 | |||||
Quick Ratio | 1.74 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 109.08 | |||||
Days Sales Outstanding | 61.83 | |||||
Days Payable | 193.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.06 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | 51.4 | |||||
Forward Dividend Yield % | 5.06 | |||||
5-Year Yield-on-Cost % | 23.94 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 11.46 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.11 | |||||
Operating Margin % | 23.94 | |||||
Net Margin % | 19.66 | |||||
FCF Margin % | 7.11 | |||||
ROE % | 23.09 | |||||
ROA % | 13.47 | |||||
ROIC % | 26.42 | |||||
ROC (Joel Greenblatt) % | 51.76 | |||||
ROCE % | 26.04 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 5.33 | |||||
Forward PE Ratio | 5.1 | |||||
PE Ratio without NRI | 5.35 | |||||
Shiller PE Ratio | 17 | |||||
Price-to-Owner-Earnings | 7.62 | |||||
PEG Ratio | 0.36 | |||||
PS Ratio | 1.05 | |||||
PB Ratio | 1.13 | |||||
Price-to-Tangible-Book | 1.14 | |||||
Price-to-Free-Cash-Flow | 14.71 | |||||
Price-to-Operating-Cash-Flow | 5.89 | |||||
EV-to-EBIT | 3.43 | |||||
EV-to-Forward-EBIT | 5.56 | |||||
EV-to-EBITDA | 2.94 | |||||
EV-to-Forward-EBITDA | 4.63 | |||||
EV-to-Revenue | 0.85 | |||||
EV-to-Forward-Revenue | 0.73 | |||||
EV-to-FCF | 11.51 | |||||
Price-to-Projected-FCF | 0.59 | |||||
Price-to-Median-PS-Value | 1.05 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.36 | |||||
Price-to-Graham-Number | 0.52 | |||||
Price-to-Net-Current-Asset-Value | 2.62 | |||||
Earnings Yield (Greenblatt) % | 29.15 | |||||
FCF Yield % | 6.79 | |||||
Forward Rate of Return (Yacktman) % | 22.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
United Laboratories International Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 15,028.401 | ||
EPS (TTM) (HK$) | 1.626 | ||
Beta | 0.67 | ||
Volatility % | 38.21 | ||
14-Day RSI | 49.23 | ||
14-Day ATR (HK$) | 0.339962 | ||
20-Day SMA (HK$) | 8.74 | ||
12-1 Month Momentum % | 26.65 | ||
52-Week Range (HK$) | 6.51 - 10.78 | ||
Shares Outstanding (Mil) | 1,817.03 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
United Laboratories International Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
United Laboratories International Holdings Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
United Laboratories International Holdings Ltd Frequently Asked Questions
What is United Laboratories International Holdings Ltd(HKSE:03933)'s stock price today?
The current price of HKSE:03933 is HK$8.67. The 52 week high of HKSE:03933 is HK$10.78 and 52 week low is HK$6.51.
When is next earnings date of United Laboratories International Holdings Ltd(HKSE:03933)?
The next earnings date of United Laboratories International Holdings Ltd(HKSE:03933) is .
Does United Laboratories International Holdings Ltd(HKSE:03933) pay dividends? If so, how much?
The Dividend Yield %  of United Laboratories International Holdings Ltd(HKSE:03933) is 5.06% (As of Today), Highest Dividend Payout Ratio of United Laboratories International Holdings Ltd(HKSE:03933) was 0.21. The lowest was 0.13. And the median was 0.17. The  Forward Dividend Yield % of United Laboratories International Holdings Ltd(HKSE:03933) is 5.06%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |